Skip to main content
Clinical Trials/JPRN-UMIN000047574
JPRN-UMIN000047574
Not Yet Recruiting
N/A

An observational study to explore the effects of anamorelin on gut microbiota in patients with carcinoma in situ with cachexia - ACADEMIC study

Cancer Treament Center, Kansai Medical University Hospital0 sites40 target enrollmentMay 1, 2022
ConditionsCancer cachexia

Overview

Phase
N/A
Intervention
Not specified
Conditions
Cancer cachexia
Sponsor
Cancer Treament Center, Kansai Medical University Hospital
Enrollment
40
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 1, 2022
End Date
December 31, 2026
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Cancer Treament Center, Kansai Medical University Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients with a prognosis of 12 weeks or less Previous anamorelin administration Patients with concomitant severe cardiac disease Hepatic dysfunction (Child\-Pugh B or C) Difficulty with oral intake due to organic abnormalities (e.g. obstruction) of the gastrointestinal tract Other patients who are deemed inappropriate by the principal investigator

Outcomes

Primary Outcomes

Not specified

Similar Trials